KURA Latest Headlines

Kura Oncology Enhances Executive Severance, Change-in-Control Terms

at www.tipranks.com (Wed, 29-Jul 5:28 PM)

Kura Oncology’s Ziftomenib Combo Delivers 94% One-Year Survival for AML—Durable Responses and Favorable Safety Highlight Potential Shift in Standard Treatment

Market Chameleon (Fri, 12-Jun 10:53 AM)

Kura Oncology’s Darlifarnib Combo Achieves 77% Tumor Shrinkage Rate in KRAS G12C-Mutant Cancers

Market Chameleon (Tue, 26-May 7:54 AM)

Kura Oncology’s ASCO Summit Spotlight: Upcoming TD Cowen Presentation Highlights Growing Pipeline Momentum

Market Chameleon (Wed, 20-May 11:46 AM)